综上所述，芪术抗癌方可以抑制肝癌HepG2细胞增殖并诱导其凋亡，而凋亡具体上游触发机制尚不明确，待进一步研究。

    参考文献

    [1]Bertuccio P，Turati F，Carioli G，et al.Global trends and predictions in hepatocellular carcinoma mortality[J].J Hepatol，2017，67(2)：302-309.

    [2]Akinyemiju T，Abera S，Ahmed M，et al.The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global ......